Group One Trading’s Aquestive Therapeutics AQST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$25.8K Buy
+5,575
New +$24.8K ﹤0.01% 5988
2025
Q3
– Sell
-12,185
Closed -$52.7K – 8710
2025
Q2
$40.3K Sell
12,185
-16,561
-58% -$47.5K ﹤0.01% 5993
2025
Q1
$83.4K Buy
28,746
+26,805
+1,381% +$81.1K ﹤0.01% 4929
2024
Q4
$6.91K Sell
1,941
-3,454
-64% -$15.9K ﹤0.01% 6514
2024
Q3
$26.9K Buy
+5,395
New +$21K ﹤0.01% 5068
2023
Q3
– Sell
-783
Closed -$1.35K – 7612
2023
Q2
$1.29K Buy
783
+516
+193% +$933 ﹤0.01% 7210
2023
Q1
$304 Sell
267
-23,994
-99% -$20.8K ﹤0.01% 6960
2022
Q4
$21.9K Sell
24,261
-5,681
-19% -$5.33K ﹤0.01% 5544
2022
Q3
$35K Sell
29,942
-14,357
-32% -$16.2K ﹤0.01% 5677
2022
Q2
$28K Sell
44,299
-7,953
-15% -$10.6K ﹤0.01% 6023
2022
Q1
$136K Sell
52,252
-24,141
-32% -$70.5K ﹤0.01% 5192
2021
Q4
$297K Buy
76,393
+60,562
+383% +$304K ﹤0.01% 4667
2021
Q3
$69K Buy
15,831
+1,839
+13% +$7.21K ﹤0.01% 6270
2021
Q2
$56K Sell
13,992
-11,997
-46% -$47.9K ﹤0.01% 6466
2021
Q1
$135K Buy
+25,989
New +$138K ﹤0.01% 5377
2020
Q4
– Sell
-127
Closed -$761 – 6450
2020
Q3
$1K Sell
127
-6,908
-98% -$45.2K ﹤0.01% 5895
2020
Q2
$34K Buy
+7,035
New +$32.4K ﹤0.01% 4577

Other funds holding AQST

Group One Trading's AQST Position: Q3 2026 in Review

Group One Trading opened a new position in Aquestive Therapeutics (AQST) in Q3 2026: 5,575 shares worth $25.8K. The stake represents ﹤0.01% of the portfolio and ranks #5988 among its holdings. This is a return to the name: Group One Trading previously reported a position in AQST as recently as Q2 2025.

Group One Trading first reported a position in AQST in Q2 2020 and has held it in 17 quarters since. The position peaked at $297K in Q4 2021. 190 funds tracked by Wall St. Rank hold AQST as of Q3 2026.

  • Group One Trading held 5,575 shares of Aquestive Therapeutics worth $25.8K as of Q3 2026.
  • Aquestive Therapeutics was a new Group One Trading position in Q3 2026.
  • Aquestive Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #5988 holding.
  • Group One Trading first reported a position in Aquestive Therapeutics in Q2 2020 and has held it in 17 quarters since.
  • Group One Trading's Aquestive Therapeutics position peaked at $297K in Q4 2021.
  • 190 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.